ADIPOQ and rheumatoid arthritis: Nevertheless, TNF-α blockers are often used to treat rheumatoid arthritis (RA) and it was recently reported that obese RA patients receiving TNF-α blockers displayed improved fasting glucose and increased circulating adiponectin levels (Stanley et al., 2010), possibly warranting more studies in the field.